Clinical Trials

Drug Development Gene Therapy Cancer Treatment Animal Studies Cancer Research Neuroscience Experimental Treatments Immunotherapy Drug Efficacy Neurology

3 ARTICLES

last wk.

Eplontersen Fails to Cut Cardiovascular Deaths or Recurrent Events in Large ATTR-CM Trial

High baseline use of transthyretin stabilizers likely masked any incremental benefit and left prespecified subgroup signals favoring unstabilized or early-stage patients.

7 ARTICLES

last wk.

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

3 ARTICLES

last wk.

JAMA Dermatology Confirms Brepocitinib Rapidly Improves Skin Disease in Dermatomyositis

3 ARTICLES

last wk.

Study Links Right-Ventricle Failure and Mitochondrial Changes to Poor Outcomes in PH-HFpEF

3 ARTICLES

last wk.

FDA Faces Choice on Allowing Six Experimental Peptides for Compounding

4 ARTICLES

last wk.

TOFA Boosts Fat Burning in Mice While Preserving Muscle

5 ARTICLES

2w ago

Moderna and Merck Personalized mRNA Vaccine Cuts Melanoma Recurrence in Phase 3 Readout

12 ARTICLES

last mo.

FDA Panel Rejects Deramiocel Cardiac Claim After Lancet Publishes HOPE‑3 Results

3 ARTICLES

last mo.

CRISPR Base Editing Reduces Toxic Huntingtin and Eases Symptoms in Mice

22 ARTICLES

last mo.

FDA Advisers Narrowly Recommend Allowing Six Unapproved Peptides for Compounding

3 ARTICLES

last mo.

FDA Reviews Influencer-Driven Peptides as Panel Weighs Compounding Access

5 ARTICLES

last mo.

Ebola Outbreak in DRC Tops 2,000 Cases as Spread Accelerates

3 ARTICLES

last mo.

Spero Licenses Innovent’s Anti‑CD40L Antibody Outside Greater China in Up to $1.1 Billion Deal

4 ARTICLES

last mo.

Securities Suit Targets GRAIL Over NHS‑Galleri Trial Disclosures

5 ARTICLES

last mo.

Germline‑Targeting HIV Vaccine Elicits Broadly Neutralizing Antibodies in Primates

3 ARTICLES

2mo ago

University of Michigan Performs First Permanent Human Implant of Paradromics’ Wireless Brain Chip

9 ARTICLES

2mo ago

Google Attributes Yearlong REDCap Breach to UNC6508

Clinical Trials

Eplontersen Fails to Cut Cardiovascular Deaths or Recurrent Events in Large ATTR-CM Trial

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

JAMA Dermatology Confirms Brepocitinib Rapidly Improves Skin Disease in Dermatomyositis

Study Links Right-Ventricle Failure and Mitochondrial Changes to Poor Outcomes in PH-HFpEF

FDA Faces Choice on Allowing Six Experimental Peptides for Compounding

TOFA Boosts Fat Burning in Mice While Preserving Muscle

Moderna and Merck Personalized mRNA Vaccine Cuts Melanoma Recurrence in Phase 3 Readout

FDA Panel Rejects Deramiocel Cardiac Claim After Lancet Publishes HOPE‑3 Results

CRISPR Base Editing Reduces Toxic Huntingtin and Eases Symptoms in Mice

FDA Advisers Narrowly Recommend Allowing Six Unapproved Peptides for Compounding

Never miss stories about

Clinical Trials

FDA Reviews Influencer-Driven Peptides as Panel Weighs Compounding Access

Ebola Outbreak in DRC Tops 2,000 Cases as Spread Accelerates

Spero Licenses Innovent’s Anti‑CD40L Antibody Outside Greater China in Up to $1.1 Billion Deal

Securities Suit Targets GRAIL Over NHS‑Galleri Trial Disclosures

Germline‑Targeting HIV Vaccine Elicits Broadly Neutralizing Antibodies in Primates

Investors File Suits After GRAIL’s NHS‑Galleri Trial Misses Primary Endpoint

Pakistan Genome Resource Maps Thousands of Human Gene Knockouts

Biogen to Buy RayThera for Up to $1 Billion

University of Michigan Performs First Permanent Human Implant of Paradromics’ Wireless Brain Chip

Google Attributes Yearlong REDCap Breach to UNC6508

Never miss stories about

Clinical Trials